Clinical benefits of immune checkpoint inhibitors for malignant peripheral nerve sheath tumors with NF2 mutation: a case report by Yale Jiang, Guo Zhao, Qiyu Tang, Shujun Xing, Shuhang Wang, Ning Li

Get full text

Trends of drug licensing in China: From bring-in to go-global by Yale Jiang, Guo Zhao, Linlin Jia, Cheng Li, Xin Wang, Jing Cai, Huiyao Huang, Shuhang Wang, Ning Li

Get full text

Nitrogen cycling and functional gene diversity of drinking reservoir area in agricultural districts: Implications for nitrogen transformation processes by Mengze Li, Wenwen Wang, Shengwu Yuan, Kun Wang, Shuhang Wang, Wei Li, Xia Jiang, Wenqiang Zhang, Baoqing Shan

Get full text

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma by Shuhang Wang, Qiuping Liang, Yujia Chi, Minglei Zhuo, Tongtong An, Jianchun Duan, Zhijie Wang, Yuyan Wang, Jia Zhong, Xue Yang, Hanxiao Chen, Jie Wang, Jun Zhao

Get full text

Targeting rare tumors: new focus for clinical research in China by Shuhang Wang, Yale Jiang, Huilei Miao, Yuan Fang, Ning Jiang, Yue Yu, Peiwen Ma, Qiyu Tang, Dandan Cui, Hong Fang, Huiyao Huang, Qi Fan, Chao Sun, Anqi Yu, Shuangman Miao, Jingting Du, Jingxiao Zhu, Yuning Wang, Ning Li

Get full text

Phase 1, open-label, multicenter, dose escalation safety and tolerability study of oncolytic virus OVV-01 in advanced solid tumors by Yan Wang, Ning Li, Qiang Lin, Fan Li, Fan Zhang, Shuhang Wang, Yingqi Hua, Hui Wu, Liang Ma, Yinying Lu, Haitao Liu, Peng Yuan, Chongren Wang, Yanjie Han, Dongqing Zuo, Yu Lv, Mengxiong Sun, Ruirong Yuan, Guoqing Zhou

Get full text

The state of the art of bispecific antibodies for treating human malignancies by Shuhang Wang, Kun Chen, Qi Lei, Peiwen Ma, Andy Qingan Yuan, Yong Zhao, Youwei Jiang, Hong Fang, Shujun Xing, Yuan Fang, Ning Jiang, Huilei Miao, Minghui Zhang, Shujun Sun, Zicheng Yu, Wei Tao, Qi Zhu, Yingjie Nie, Ning Li

Get full text